Andere talen SUNE BIOP OTC Markets

Aandelen

SBFM

US8677812054

Vertraagde tijd OTC Markets Andere beurzen 17:15:16 05-10-2021			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,1175 ^USD	-1,26%		+0,34%	+657,96%

12/04	Aandelen Sunshine Biopharma dalen na aankondiging van omgekeerde aandelensplitsing	MT
28/03	Sunshine Biopharma, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Certain Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-MAY-2024.	13/05
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	22/04
Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	19/04
Top Premarket Decliners	19/04
Sunshine Biopharma Announces Reverse Stock Split	15/04
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement	12/04
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	28/03
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Sunshine Biopharma, Inc. announced that it has received $5 million in funding	28/03
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	06/03
Sunshine Biopharma, Inc. announced that it expects to receive $0.01 million in funding	04/03
Sunshine Biopharma, Inc. Announces Executive Changes	30/01
Sunshine Biopharma Moves Principal Office to New York City	04/12
Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City	04/12
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	13/11
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc	02/11
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule	22-09-23
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	11-08-23
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	10-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen SUNE BIOP OTC Markets

Aandelen

SBFM

US8677812054

Andere talen

Filters